Paclitaxel - 61703-342-22 - (PACLITAXEL)

Alphabetical Index


Drug Information of Paclitaxel

Product NDC: 61703-342
Proprietary Name: Paclitaxel
Non Proprietary Name: PACLITAXEL
Active Ingredient(s): 6    mg/mL & nbsp;   PACLITAXEL
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Paclitaxel

Product NDC: 61703-342
Labeler Name: Hospira Worldwide, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076131
Marketing Category: ANDA
Start Marketing Date: 20020508

Package Information of Paclitaxel

Package NDC: 61703-342-22
Package Description: 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-22) > 16.7 mL in 1 VIAL, MULTI-DOSE

NDC Information of Paclitaxel

NDC Code 61703-342-22
Proprietary Name Paclitaxel
Package Description 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-22) > 16.7 mL in 1 VIAL, MULTI-DOSE
Product NDC 61703-342
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name PACLITAXEL
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20020508
Marketing Category Name ANDA
Labeler Name Hospira Worldwide, Inc.
Substance Name PACLITAXEL
Strength Number 6
Strength Unit mg/mL
Pharmaceutical Classes Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]

Complete Information of Paclitaxel


General Information